– About us –

THE SALZMAN GROUP

The Salzman Group is a global drug development company that seeks to transform medical practice by undertaking transformative pharmaceutical innovation. We meet this objective by creating and developing our own drugs and those of others, serving both as an internal research engine and as a boutique contract service organization.

For more than 25 years, the scientific team at Salzman Group has worked as a close-knit group, building a reputation for global leadership in basic science, drug development, and clinical medicine. Our expertise and professional network enable us to create groundbreaking opportunities that tackle unmet medical needs, and to customize support for our clients to overcome their drug development challenges. In the process, we have raised hundreds of millions of dollars for our own efforts and those of our clients, and have pioneered new pharmaceutical technologies resulting in strategic exits, initial public offerings, grant and contract funding, and intellectual property. Whether working with our own drugs or those of our clients, we have only one goal: to focus on pursuing discovery and development that will change the nature of 21st century medicine.

Mission

Our daily motivation is to transform medical care across the globe by scientific innovation and excellence. We are pursuing this by developing our own drug candidates and supporting the projects of our clients.



WE SEEK TO TRANSFORM THE PRACTICE OF MEDICINE BY PIONEERING INNOVATIVE THERAPEUTICS.


- TRACK RECORD -

MILESTONES

0

US Patents

0

Peer-reviewed publications

0

Phase I Clinical Trials

0

Phase II Clinical Trials

FUNDING

$0M

Venture Capital Funding

$0M

Strategic Licensing

$0M

US Federal Funding

0USA

Federal Contracts

back to top